Form 4: Vita Coco CFO Sells Shares Under 10b5-1 Plan
Insider Trading Report (Form 4)
Vita Coco Company's Chief Financial Officer, Corey Baker, sold 2,000 shares of common stock through a pre-arranged 10b5-1 trading plan.
Summary
- Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), sold a total of 2,000 shares of common stock.
- The sales occurred on September 9, 2025, and September 10, 2025.
- On September 9, 2025, 1,000 shares were sold at a price of $38.40 per share.
- On September 10, 2025, another 1,000 shares were sold at a price of $38.16 per share.
- These transactions were executed pursuant to a Rule 10b5-1 trading plan, which allows insiders to sell shares at a predetermined time or price to avoid accusations of insider trading.
- Following these sales, Mr. Baker beneficially owns 39,754 shares of common stock.
- Mr. Baker also holds various non-qualified stock options, including 14,205 options at an exercise price of $16.91, 13,481 options at $24.35, 8,746 options at $26.18, 11,547 options at $27.59, and 13,218 options at $33.36, all with specific vesting schedules.
Sentiment
Score: 5
Explanation: The sale of shares by the CFO is a neutral event given it was executed under a pre-arranged 10b5-1 plan, which mitigates concerns about opportunistic selling. The CFO retains significant equity and options, indicating continued alignment with company performance.
Positives
- The sales were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reaction to recent non-public information, which mitigates concerns often associated with insider sales.
- The Chief Financial Officer retains a significant number of shares (39,754) and substantial stock options, indicating continued alignment with shareholder interests.
Negatives
- Insider sales, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as they represent a reduction in direct ownership by a key executive.
- The sales occurred at prices of $38.40 and $38.16, which could be interpreted as the CFO taking profits at current valuation levels.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- The sale of common stock by Corey Baker, the Chief Financial Officer, constitutes a related party transaction as it involves an executive officer of the company. These transactions were executed under a Rule 10b5-1 trading plan.
Stakeholder Impact
- Shareholders: May view the insider sale with slight caution, though the 10b5-1 plan mitigates concerns. The reduction in direct insider ownership is minor relative to total holdings.
- Employees: No direct impact on employees is indicated by this filing.
- Customers: No direct impact on customers is indicated by this filing.
- Suppliers: No direct impact on suppliers is indicated by this filing.
- Creditors: No direct impact on creditors is indicated by this filing.
Next Steps
- Continued vesting of various non-qualified stock options on their respective schedules, including on March 10, 2025, August 7, 2025, March 10, 2026, August 7, 2026, March 10, 2027, August 7, 2027, and annual anniversaries for the $33.36 options.
Key Dates
| Date | Description |
|---|---|
| 03/10/2024 | First annual vesting installment for 14,205 stock options with an exercise price of $16.91. |
| 03/04/2025 | First annual vesting installment for 8,746 stock options with an exercise price of $26.18. |
| 03/10/2025 | Vesting of 30% of 13,481 stock options with an exercise price of $24.35. |
| 08/07/2025 | Vesting of 30% of 11,547 stock options with an exercise price of $27.59. |
| 09/09/2025 | Sale of 1,000 shares of common stock by Corey Baker at $38.40 per share. |
| 09/10/2025 | Sale of 1,000 shares of common stock by Corey Baker at $38.16 per share. |
| 09/11/2025 | Signature date of the Form 4 filing. |
| 03/10/2026 | Vesting of 20% of 13,481 stock options with an exercise price of $24.35. |
| 08/07/2026 | Vesting of 20% of 11,547 stock options with an exercise price of $27.59. |
| 03/10/2027 | Vesting of 10% of 13,481 stock options with an exercise price of $24.35. |
| 08/07/2027 | Vesting of 10% of 11,547 stock options with an exercise price of $27.59. |
| 03/10/2033 | Expiration date for 14,205 non-qualified stock options with an exercise price of $16.91. |
| 05/10/2033 | Expiration date for 13,481 non-qualified stock options with an exercise price of $24.35. |
| 08/07/2033 | Expiration date for 11,547 non-qualified stock options with an exercise price of $27.59. |
| 03/04/2034 | Expiration date for 8,746 non-qualified stock options with an exercise price of $26.18. |
| 03/04/2035 | Expiration date for 13,218 non-qualified stock options with an exercise price of $33.36. |
Recommendation
holdThe insider sale by the CFO, while a reduction in direct ownership, was executed under a pre-arranged 10b5-1 plan, which suggests it was not based on new, material non-public information. The CFO retains substantial equity and options, indicating continued alignment with the company's performance. Without additional financial or strategic information, this transaction alone does not warrant a change from a 'hold' position.
Keywords
Vita Coco Company, COCO, Corey Baker, CFO, Insider Sale, Form 4, 10b5-1 Plan, Stock Options, Beneficial Ownership, Beverage Industry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.